文献速递呼吸道感染

人气道类器官与离体支气管培养中流感病毒的嗜性、复制能力及天然免疫反应

Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures.
PubMed 文献 · Lancet Respir Med · 2018-07-11

该研究比较了人及禽流感病毒在离体人支气管与人气道类器官中的复制能力、组织嗜性和宿主反应。结果显示类器官与支气管外植体的病毒嗜性和复制动力学相似,H1N1与H7N9复制滴度显著高于HPAI H5N1,HPAI H5N1诱导的细胞因子和趋化因子表达显著更高。

要点

  • 人气道类器官可替代离体支气管培养评估流感病毒嗜性与复制能力。
  • H1N1与H7N9在类器官和支气管外植体中复制滴度显著高于HPAI H5N1。
  • HPAI H5N1感染类器官诱导IL-6、IFN-β、RANTES和MCP-1表达显著更高。

核心结论

  • 人气道类器官培养结果与离体人支气管培养相当,可作为研究病毒嗜性和复制能力的生理相关替代模型。

研究设计与样本

  • 研究于2016年9月29日至2017年1月4日获取人离体支气管培养及人肺干细胞来源的气道类器官。
  • 比较人源禽流感病毒Sh2/H7N9、H5N1/483、H5N6/39715与人H1N1pdm/415742的复制能力、组织嗜性及细胞因子和趋化因子诱导。

主要发现

  • 人及禽流感病毒在人气道类器官中的嗜性和复制动力学与离体人支气管外植体所见相似。
  • 在类器官和支气管外植体中,H1N1与H7N9复制滴度显著高于HPAI H5N1,HPAI H5N6复制为中等水平。
  • H1N1、H7N9和H5N6感染纤毛细胞和杯状细胞,但不感染基底层细胞。
  • HPAI H5N1感染类器官中IL-6、IFN-β和RANTES表达显著高于H1N1pdm/415742、Sh2/H7N9和H5N6/39715。
  • HPAI H5N1感染类器官中MCP-1表达显著高于H1N1pdm/415742和Sh2/H7N9。

临床怎么用

  • 人气道类器官可用于评估动物流感病毒的嗜性、复制能力及大流行威胁。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human airway organoids are three-dimensional cultures derived from stem cells, which self-organise in ex-vivo conditions to form so-called mini-airways. The cellular morphology of these cultures is physiologically similar to the human airway, with cilia, goblet cells, and club cells facing the inner lumen and basal cells situated at the outer layer. The aim of this study was to compare replication competence, tissue tropism, and host responses elicited by human and avian strains of influenza A virus in ex-vivo human bronchus and human airway organoids. METHODS: Between Sept 29, 2016, and Jan 4, 2017, we obtained ex-vivo cultures of the human bronchus and cultured human airway organoids from lung stem cells obtained from human lung tissues removed as part of the routine clinical care of patients undergoing surgical resection at the Department of Cardiothoracic Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong. We compared viral replication competence, tissue tropism, and cytokine and chemokine induction of avian influenza A viruses isolated from humans (Sh2/H7N9, H5N1/483, H5N6/39715), and human H1N1pdm/415742 in airway organoids and ex-vivo bronchus explant cultures. FINDINGS: Virus tropism and replication kinetics of human and avian influenza A viruses in human airway organoids mimicked those found in ex-vivo cultures of human bronchus explants. In both airway organoids and bronchus explants, influenza A H1N1 subtype (H1N1) and avian influenza A H7N9 viruses replicated to significantly higher titres than did the highly pathogenic avian influenza (HPAI) H5N1, whereas HPAI H5N6 replication was moderate. H1N1, H7N9, and H5N6 viruses infected ciliated cells and goblet cells, but not basal cells in both airway organoids and bronchus explants. The expression of cytokines, interleukin 6, and interferon β, and the chemokine regulated-on-activation, normal T-cell expressed and secreted, was significantly higher in human airway organoids infected with HPAI H5N1 virus than H1N1pdm/415742, Sh2/H7N9, and H5N6/39715 viruses, and the expression of monocyte chemoattractant protein-1 was significantly higher in human organoids infected with HPAI H5N1 virus than H1N1pdm/415742 and Sh2/H7N9 viruses. INTERPRETATION: Human airway organoid cultures provided results that were comparable to those observed in human ex-vivo bronchus cultures, and thus provide an alternative physiologically relevant experimental model for investigating virus tropism and replication competence that could be used to assess the pandemic threat of animal influenza viruses. FUNDING: US National Institute of Allergy and Infectious Diseases, Research Grants Council of the Hong Kong Special Administrative Region.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Hui KPY, Ching RHH, Chan SKH, et al. Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures. Lancet Respir Med. 2018. PMID: 30001996. doi:10.1016/S2213-2600(18)30236-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。